Type 2 diabetes mellitus (T2DM), one of the most common carbohydrate metabolism
disorders, is characterized by chronic hyperglycemia and insulin resistance (IR), and has …

Numerous studies have proposed the transplantation of mesenchymal stem cells (MSCs) in
the treatment of typical type 2 diabetes mellitus (T2DM). We aimed to find a new strategy …

摘要目的: 探讨低剂量脂多糖(LPS) 预处理的间充质干细胞(MSCs) 对于胰岛移植物的保护作用
及其机制. 方法: 给予MSCs 不同浓度的LPS 预处理, 利用流式细胞仪检测不同处理组的间充质 …

The aim of this study was to differentiate canine adipose-derived mesenchymal stem cells
(ADMSCs) into insulin-producing cells by using culture media with different compositions to …

05). Oil red O staining demonstrated that lipid droplet number was significantly less in the
each adipogenic inductor+ extracting solution from Eucommia ulmoides Oliv. groups …

目的比较幼龄1 型糖尿病(T1DM) 模型小鼠和幼龄正常小鼠脂肪来源干细胞(ADSC)
的成脂分化能力, 为阐明T1DM 发病机制提供理论基础和实验依据. 方法3 周龄C57BL/6J 小鼠 …

Cell therapy is thought to be a possible approach for treatment of diabetes. Cells with the
ability to differentiate into insulin-producing cells (IPCs) would provide an unlimited source …

The worldwide increase in the prevalence of diabetes mellitus has raised the demand for
new therapeutic strategies targeting diabetic symptoms and its chronic complications …

Objective: Mesenchymal stem cells (MSCs) are increasingly trialed in cellular therapy
applications in humans to treat several degenerative and inflammatory disorders. Not only …